fella glp-1 (@fellahealth) • Instagram photos and videos What Is GLP-1 Balance? Understanding

The SURPASS-CVOT trial is a phase 3, randomized, double-blind cardiovascular outcomes trial that will assess tirzepatide for both non-inferiority and superiority against dulaglutide. For dulaglutide, this effect is already proven: According to the Trulicity website, the drug may be used in adults with type 2 diabetes to reduce the risk of major cardiovascular events (problems having to do with the heart and blood vessels) such as death, heart attack, or stroke in people who have heart disease or multiple cardiovascular risk factors. How do I know which medication is right for me

What is the current scientific data on the safety of GLP-1 agonists and SGLT2 inhibitors during pregnancy and/or lactation

0.81] was observed after 6 months

Responses may be automated, but your coach reviews interactions to ensure quality and support

those prioritizing oral administration despite reduced convenience and efficacy

Alcohol may also irritate your stomach and worsen GI side effects